- Home
- CC vs VERA Comparison
CC vs VERA Comparison
Compare CC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- VERA
- Stock Information
- Founded
- CC 2014
- VERA 2016
- Country
- CC United States
- VERA United States
- Employees
- CC N/A
- VERA N/A
- Industry
- CC Major Chemicals
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- CC Industrials
- VERA Health Care
- Exchange
- CC Nasdaq
- VERA Nasdaq
- Market Cap
- CC 2.9B
- VERA 2.8B
- IPO Year
- CC N/A
- VERA 2021
- Fundamental
- Price
- CC $18.24
- VERA $43.53
- Analyst Decision
- CC Buy
- VERA Strong Buy
- Analyst Count
- CC 8
- VERA 9
- Target Price
- CC $24.88
- VERA $59.22
- AVG Volume (30 Days)
- CC 1.7M
- VERA 434.6K
- Earning Date
- CC 11-04-2024
- VERA 11-07-2024
- Dividend Yield
- CC 5.51%
- VERA N/A
- EPS Growth
- CC N/A
- VERA N/A
- EPS
- CC 0.50
- VERA N/A
- Revenue
- CC $5,749,000,000.00
- VERA N/A
- Revenue This Year
- CC N/A
- VERA N/A
- Revenue Next Year
- CC $5.08
- VERA N/A
- P/E Ratio
- CC $36.20
- VERA N/A
- Revenue Growth
- CC N/A
- VERA N/A
- 52 Week Low
- CC $15.10
- VERA $14.20
- 52 Week High
- CC $32.70
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- CC 34.27
- VERA 40.02
- Support Level
- CC $18.13
- VERA $43.02
- Resistance Level
- CC $22.27
- VERA $49.77
- Average True Range (ATR)
- CC 0.81
- VERA 1.85
- MACD
- CC -0.41
- VERA -0.69
- Stochastic Oscillator
- CC 4.11
- VERA 13.58
About CC Chemours Company (The)
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.